EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Basics of diagnosis and treatment of venous thromboembolism

Catrin Cox, Lara N Roberts

Journal of Thrombosis and Haemostasis · 2025

DOI: 10.1016/j.jtha.2025.01.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Catrin Cox und 1 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis and Haemophilia Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK. Hauptthemen laut MEDLINE: Venous Thromboembolism, Anticoagulants, Pulmonary Embolism, Venous Thrombosis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venous thromboembolism (VTE), comprising deep vein thrombosis and pulmonary embolism (PE), is common and associated with significant morbidity and mortality. The symptoms and signs of VTE are nonspecific. Well-established integrated diagnostic strategies combining clinical probability scores and D-dimer are used to identify patients with a low probability of VTE, where the diagnosis can be safely excluded without imaging. In patients with confirmed VTE, anticoagulation is the mainstay of treatment. However, patients with high-risk features at presentation may benefit from advanced reperfusion therapies such as thrombolysis and/or interventional approaches to reduce early mortality and/or long-term morbidity. The advent of direct oral anticoagulants has greatly simplified the treatment of VTE for most patients, with a persisting role for low molecular weight heparin and vitamin K antagonists in select patient groups. Following an initial 3 to 6 months of anticoagulation, those with major transient provoking factors can safely discontinue anticoagulation. Balancing the risk of recurrent VTE and bleeding risk is central to decisions regarding long-term anticoagulation, and patients should be included in shared decision-making. Assessment and recognition of common long-term complications such as postthrombotic syndrome and post-PE syndrome are also essential, given they are associated with significant adverse impact on long-term quality of life, with a significant risk of mortality associated with the less frequent complication of chronic thromboembolic pulmonary hypertension. This review provides a basic overview and framework for the diagnostic approach to deep vein thrombosis and PE, risk stratification of confirmed diagnoses, and management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismAnticoagulantsPulmonary EmbolismVenous ThrombosisBlood CoagulationHumansRisk FactorsTreatment OutcomeHemorrhagePredictive Value of TestsRisk AssessmentFibrin Fibrinogen Degradation ProductsRecurrence

Stichwörter der Autor:innen

anticoagulantspulmonary embolismvenous thromboembolismvenous thrombosis

Substanzen

AnticoagulantsFibrin Fibrinogen Degradation Products

Autor:innen und Institutionen

  • Thrombosis and Haemophilia Centre, Guy's & St Thomas' NHS Foundation Trust, London, UK.
  • King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK; Institute of Pharmaceutical Sciences, King's College London, London, UK. Electronic address: lar…

Zitieren

APA

Cox, C., & Roberts, L. N. (2025). Basics of diagnosis and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.01.009

Vancouver

Cox C, Roberts LN. Basics of diagnosis and treatment of venous thromboembolism. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2025.01.009

BibTeX
@article{Cox2025,
  author = {Cox, Catrin and Roberts, Lara N},
  title = {Basics of diagnosis and treatment of venous thromboembolism},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2025},
  doi = {10.1016/j.jtha.2025.01.009}
}
Kostenlos starten →